CRC 1530 "Elucidation and targeting of pathogenic mechanisms in B cell malignancies" has been awarded follow-up funding by the Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation and we couldn't be happier and more grateful.
Late nights, lively debates, and a shared obsession with B cell malignancies have paid off. This continued support means we get to keep doing what we love: digging into the mechanisms driving B cell cancers and working towards better, more targeted therapies for patients.
A huge thank you to every researcher, collaborator, and coffee machine that made this possible. ☕
Here's to the next chapter — more science, more breakthroughs, and hopefully a few more questions answered.
